Page last updated: 2024-09-03

celastrol and glycyrrhetinic acid

celastrol has been researched along with glycyrrhetinic acid in 5 studies

Compound Research Comparison

Studies
(celastrol)
Trials
(celastrol)
Recent Studies (post-2010)
(celastrol)
Studies
(glycyrrhetinic acid)
Trials
(glycyrrhetinic acid)
Recent Studies (post-2010) (glycyrrhetinic acid)
8851741102067

Protein Interaction Comparison

ProteinTaxonomycelastrol (IC50)glycyrrhetinic acid (IC50)
Aldo-keto reductase family 1 member B10Homo sapiens (human)4.9
Corticosteroid 11-beta-dehydrogenase isozyme 1 Rattus norvegicus (Norway rat)0.09
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)0.1853
Corticosteroid 11-beta-dehydrogenase isozyme 1Mus musculus (house mouse)0.0124
Corticosteroid 11-beta-dehydrogenase isozyme 2Rattus norvegicus (Norway rat)0.36
Corticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)0.1035
Tyrosine-protein phosphatase non-receptor type 11Homo sapiens (human)9.6
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)0.5495
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)0.5248

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Brooks, WH; Chen, L; Daniel, KG; Guida, WC; Lawrence, HR; Lawrence, NJ; Scott, LM; Sebti, SM; Wu, J1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Huang, R; Huang, X; Ji, M; Jin, L; Wang, H; Zhang, B1
Song, Y; Wang, S; Yang, X; Yu, B; Zhao, M1
Chang, YH; Hung, HY1

Reviews

2 review(s) available for celastrol and glycyrrhetinic acid

ArticleYear
Strategies Targeting Protein Tyrosine Phosphatase SHP2 for Cancer Therapy.
    Journal of medicinal chemistry, 2022, 02-24, Volume: 65, Issue:4

    Topics: Animals; Antineoplastic Agents; Drug Design; Drug Discovery; Enzyme Inhibitors; Humans; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11

2022
Recent advances in natural anti-obesity compounds and derivatives based on in vivo evidence: A mini-review.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Animals; Anti-Obesity Agents; Drug Discovery; Obesity; Phytochemicals

2022

Other Studies

3 other study(ies) available for celastrol and glycyrrhetinic acid

ArticleYear
Shp2 protein tyrosine phosphatase inhibitor activity of estramustine phosphate and its triterpenoid analogs.
    Bioorganic & medicinal chemistry letters, 2011, Jan-15, Volume: 21, Issue:2

    Topics: Antineoplastic Agents, Hormonal; Estramustine; Humans; Models, Molecular; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Structure-Activity Relationship; Triterpenes

2011
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
    Bioorganic & medicinal chemistry, 2018, 05-01, Volume: 26, Issue:8

    Topics: Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chaperonins; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glycyrrhetinic Acid; HSP90 Heat-Shock Proteins; Humans; Molecular Structure; Structure-Activity Relationship

2018